ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LXRX Lexicon Pharmaceuticals Inc

1.58
0.04 (2.60%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,271,998
Bid Price 1.58
Ask Price 1.63
News -
Day High 1.61

Low
0.92

52 Week Range

High
3.789

Day Low 1.53
Share Name Share Symbol Market Stock Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.04 2.60% 1.58 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.55 1.53 1.61 1.58 1.54
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,805 1,271,998 US$ 1.57 US$ 2,000,537 - 0.92 - 3.789
Last Trade Type Quantity Price Currency
17:34:31 5 US$ 1.6193 USD

Lexicon Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
386.98M 244.92M - 1.2M -177.12M -0.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lexicon Pharmaceuticals News

Date Time Source News Article
4/18/202407:00GlobeNewswire Inc.Lexicon Pharmaceuticals to Host 2024 Investor Day
4/03/202407:00GlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the 23rd Annual..
3/25/202408:20GlobeNewswire Inc.Clinical Data on the Impact of Sotagliflozin on Stroke and..
3/12/202407:00GlobeNewswire Inc.New Post Hoc Analysis of inTandem3 Study Demonstrates..
3/11/202415:25Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
3/11/202406:26Edgar (US Regulatory)Form 8-K - Current report
3/11/202406:15GlobeNewswire Inc.Lexicon Pharmaceuticals Reports Fourth Quarter..
3/11/202406:05GlobeNewswire Inc.Lexicon Announces Oversubscribed $250 Million Private..
3/11/202406:00GlobeNewswire Inc.Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1..
2/29/202415:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/12/202415:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LXRX Message Board. Create One! See More Posts on LXRX Message Board See More Message Board Posts

Historical LXRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.631.85751.521.642,815,134-0.05-3.07%
1 Month2.452.451.521.832,771,561-0.87-35.51%
3 Months2.053.731.522.474,642,334-0.47-22.93%
6 Months1.143.730.922.043,614,6460.4438.60%
1 Year2.393.7890.922.052,976,571-0.81-33.89%
3 Years4.976.32990.922.481,508,874-3.39-68.21%
5 Years5.659.650.923.231,913,847-4.07-72.04%

Lexicon Pharmaceuticals Description

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Your Recent History

Delayed Upgrade Clock